SE7907631L - Forfarande for framstellning av 1alfa-hydroxylerade foreningar - Google Patents

Forfarande for framstellning av 1alfa-hydroxylerade foreningar

Info

Publication number
SE7907631L
SE7907631L SE7907631A SE7907631A SE7907631L SE 7907631 L SE7907631 L SE 7907631L SE 7907631 A SE7907631 A SE 7907631A SE 7907631 A SE7907631 A SE 7907631A SE 7907631 L SE7907631 L SE 7907631L
Authority
SE
Sweden
Prior art keywords
1alfa
procedure
preparation
hydroxylated compounds
hydroxylated
Prior art date
Application number
SE7907631A
Other languages
English (en)
Other versions
SE429971B (sv
Inventor
Luca H F De
H K Schnoes
D E Hamer
H E Paaren
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of SE7907631L publication Critical patent/SE7907631L/sv
Publication of SE429971B publication Critical patent/SE429971B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
SE7907631A 1978-01-16 1979-09-13 Forfarande for framstellning av 1alfa-hydroxylerade foreningar SE429971B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86944878A 1978-01-16 1978-01-16
US05/914,796 US4195027A (en) 1978-01-16 1978-06-12 Process for preparing 1α-hydroxylated compounds

Publications (2)

Publication Number Publication Date
SE7907631L true SE7907631L (sv) 1979-09-13
SE429971B SE429971B (sv) 1983-10-10

Family

ID=27128114

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7907631A SE429971B (sv) 1978-01-16 1979-09-13 Forfarande for framstellning av 1alfa-hydroxylerade foreningar

Country Status (15)

Country Link
US (1) US4195027A (sv)
JP (1) JPS5828876B2 (sv)
AU (1) AU525781B2 (sv)
BE (1) BE873512A (sv)
CA (1) CA1156251A (sv)
CH (2) CH653321A5 (sv)
DE (2) DE2933189T1 (sv)
DK (3) DK147912C (sv)
FR (4) FR2438035A1 (sv)
GB (1) GB2013686B (sv)
IE (1) IE48547B1 (sv)
NL (1) NL188901C (sv)
NZ (1) NZ189388A (sv)
SE (1) SE429971B (sv)
WO (1) WO1979000513A1 (sv)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16989A (en) * 1978-11-07 1984-05-04 Res Inst Medicine Chem Process for the preparation of 1-hydroxylated vitamin d compounds
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same
JPS5626820A (en) * 1979-08-10 1981-03-16 Chugai Pharmaceut Co Ltd Immunosuppressing agent
US4265822A (en) * 1979-09-10 1981-05-05 Wisconsin Alumni Research Foundation Process for preparing 1-hydroxylated vitamin D compounds from 5,6-trans-vitamin D compounds
US4297289A (en) * 1980-07-17 1981-10-27 Wisconsin Alumni Research Foundation Vitamin D compounds isotopically substituted at carbon 6 and process for their preparation
ATE19623T1 (de) * 1981-07-17 1986-05-15 Duphar Int Res Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen.
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
IE58277B1 (en) * 1983-05-09 1993-08-25 Wisconsin Alumni Res Found 1 , 25-dihydroxylated vitamin d2 compounds and intermediates in the preparation thereof
JPH064536B2 (ja) * 1984-03-05 1994-01-19 ウイスコンシン アラムナイ リサ−チ フオンデ−シヨン １α―ヒドロキシビタミンＤ２類似体を使用する家禽の骨の鉱質化促進方法
US4555364A (en) * 1984-11-01 1985-11-26 Wisconsin Alumni Research Foundation Method for preparing 1-hydroxyvitamin D compounds
AU603340B2 (en) * 1985-08-02 1990-11-15 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
US5869473A (en) * 1988-08-02 1999-02-09 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5321018A (en) * 1989-03-09 1994-06-14 Wisconsin Alumni Research Foundation Use of 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
US5401731A (en) * 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
US5532228A (en) * 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
ES2169023T3 (es) * 1990-09-21 2002-07-01 Bone Care Int Inc Nueva 1alfa-hidroxi vitaminada d4 y nuevos intermedios y analogos.
US5801164A (en) * 1990-09-21 1998-09-01 Bone Care International, Inc. Methods of treating osteoporosis prophylactically or therapeutically
US5798345A (en) * 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
US6025346A (en) * 1990-09-21 2000-02-15 Bone Care International, Inc. 1α-hydroxy vitamin D4 and novel intermediates and analogues
US5789397A (en) * 1991-01-08 1998-08-04 Bone Care International, Inc. Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6251883B1 (en) 1991-01-08 2001-06-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
ATE240736T1 (de) * 1991-01-08 2003-06-15 Bone Care Int Inc Verfahren zur herstellung von 1-alpha-24- dihydroxy-vitamin d2
US6166000A (en) * 1991-01-08 2000-12-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
EP0614456B1 (en) * 1992-08-28 1999-06-09 Bone Care International, Inc. 1alpha,24(s)-dihydroxy vitamin d2, its formation and use
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5869472A (en) * 1994-07-18 1999-02-09 Bone Care International, Inc. Synthesis of 1α-hydroxy vitamin D
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
AU717238B2 (en) * 1995-09-21 2000-03-23 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
US5952317A (en) * 1995-09-21 1999-09-14 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
US5976784A (en) * 1996-09-20 1999-11-02 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
HUP0002454A2 (hu) * 1997-02-13 2000-12-28 Bone Care International, Inc. D-Vitamin-molekularésszel rendelkező konjugátumok és ilyen konjugátumokat tartalmazó gyógyászati készítmények
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
AU762481C (en) * 1998-03-27 2004-08-19 Oregon Health Sciences University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
WO2002006218A2 (en) * 2000-07-18 2002-01-24 Bone Care International, Inc. STABILIZED 1α-HYDROXY VITAMIN D
US7148211B2 (en) 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
WO2005102355A1 (en) * 2004-04-23 2005-11-03 Genzyme Corporation METHODS OF TREATING VARIOUS VITAMIN D METABOLISM CONDITIONS WITH 1α-HYDROXYVITAMIN D2
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7491712B1 (en) 2007-12-10 2009-02-17 Formosa Laboratories, Inc. Process for preparation of paricalcitol and intermediates thereof
CN102131773B (zh) * 2008-07-22 2014-09-24 Azad药物成分股份公司 生产帕立骨化醇的方法
WO2011002756A2 (en) * 2009-07-01 2011-01-06 Vitamin Derivatives, Inc. Vitamin d compounds and methods for preparing same
CN114805158B (zh) * 2022-04-24 2023-11-14 浙江花园生物医药股份有限公司 一种制备骨化三醇的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US3847955A (en) * 1973-07-16 1974-11-12 Wisconsin Alumni Res Found 1,24,25-trihydroxycholecalciferol
CA1034114A (en) * 1973-12-03 1978-07-04 Wisconsin Alumni Research Foundation Processes for preparation of steroid derivatives
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US3907843A (en) * 1974-06-14 1975-09-23 Wisconsin Alumni Res Found 1{60 -Hydroxyergocalciferol and processes for preparing same
US3976636A (en) * 1974-10-10 1976-08-24 The Upjohn Company Process and compounds

Also Published As

Publication number Publication date
DK147912C (da) 1985-06-17
DE2933189C2 (sv) 1991-05-29
NZ189388A (en) 1981-02-11
IE790055L (en) 1979-07-16
US4195027A (en) 1980-03-25
FR2438035B1 (sv) 1984-02-24
AU4339479A (en) 1979-07-26
WO1979000513A1 (en) 1979-08-09
DK365079A (da) 1979-08-31
NL188901B (nl) 1992-06-01
FR2478631B1 (sv) 1984-02-24
CA1156251A (en) 1983-11-01
NL188901C (nl) 1992-11-02
DK436182A (da) 1982-10-01
CH658050A5 (de) 1986-10-15
AU525781B2 (en) 1982-12-02
FR2436140A1 (fr) 1980-04-11
FR2438035A1 (fr) 1980-04-30
JPS54500080A (sv) 1979-11-29
NL7900331A (nl) 1979-07-18
GB2013686A (en) 1979-08-15
SE429971B (sv) 1983-10-10
DK147912B (da) 1985-01-07
DE2933189T1 (de) 1980-12-18
GB2013686B (en) 1982-04-15
FR2529888B1 (fr) 1986-04-04
BE873512A (fr) 1979-05-16
FR2529888A1 (fr) 1984-01-13
DE2954557C2 (sv) 1991-07-11
JPS5828876B2 (ja) 1983-06-18
DK169871B1 (da) 1995-03-20
FR2478631A1 (fr) 1981-09-25
DK374083A (da) 1983-08-16
DK170437B1 (da) 1995-09-04
DK374083D0 (da) 1983-08-16
CH653321A5 (de) 1985-12-31
IE48547B1 (en) 1985-03-06

Similar Documents

Publication Publication Date Title
SE7907631L (sv) Forfarande for framstellning av 1alfa-hydroxylerade foreningar
FI803976L (fi) Anvaendning av zinkperoxid som oxidationsmedel foer spraengaemnen och pyrotekniska blandningar
SE8300718D0 (sv) Metod och komposition for behandling av akne
ZA838072B (en) Beta-carbolines,process for their production and pharmaceutical preparations containing them
AU538039B2 (en) Pyrimido (6,1-a)isoquinolin-4-ones
OA05725A (fr) Procédé de préparation de dérivés d'acides hydroxy-aminophosphonique hydrocarbonés.
DE3662100D1 (en) Use of solvents in the production of s-triazine derivatives and method for the production of s-triazine derivatives
NO154460C (no) Fremgangsmaate for fremstilling av baa- hydroksysmoersyre og oligokondensater derav.
KR870003981A (ko) 클라우센아미드의 제조 방법
DE3574471D1 (de) 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DE58907417D1 (de) Verfahren zur Herstellung von Addukten von 1,2-Butylenoxid an Alkohole.
PT70560A (de) 1,3,4-thiadiazol-2-carbonsaure-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende fungizide und nematizide mittel
SE7904396L (sv) Sett att framstella arylettiksyraderivat
SE7704110L (sv) Forfarande for framstellning och rening av sekretin
NO910361D0 (no) Hydrokarbonylderivater og fremgangsmaate for fremstilling av disse.
FR2442230A1 (fr) Procede de preparation de dienones du type narwedine et de leurs derives
ATE76868T1 (de) Verfahren zur herstellung von 1,2-disulfonverbindungen.
DE3462881D1 (en) Process for the preparation of 2,2,2 trifluoroethanol
SE7509607L (sv) Forfarnde for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat
BG33282A3 (en) Method for obtaining of 4- amino- 5- chlorine- 1- phenylpyridazon- (6)
ATE68487T1 (de) Verfahren zur herstellung eines 2,3dihydroxychinoxalins.
JPS52111923A (en) Production of quinozolone derivative
DE3166723D1 (en) Process for the preparation of substituted glyoxylic acid derivatives
ES465462A1 (es) Procedimiento para preparar productos de oxidacion de com- puesto de monoalcohil-benceno.
IL69416A0 (en) Process for inverting the configuration of optically active compounds,and optically active intermediates produced in the process

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7907631-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7907631-1

Format of ref document f/p: F